JPH0310659A - Iron-rich hemoferrum and production thereof - Google Patents
Iron-rich hemoferrum and production thereofInfo
- Publication number
- JPH0310659A JPH0310659A JP1144427A JP14442789A JPH0310659A JP H0310659 A JPH0310659 A JP H0310659A JP 1144427 A JP1144427 A JP 1144427A JP 14442789 A JP14442789 A JP 14442789A JP H0310659 A JPH0310659 A JP H0310659A
- Authority
- JP
- Japan
- Prior art keywords
- iron
- heme
- heme iron
- blood
- iron content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims description 225
- 229910052742 iron Inorganic materials 0.000 title claims description 114
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 210000004369 blood Anatomy 0.000 claims abstract description 24
- 239000008280 blood Substances 0.000 claims abstract description 24
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 22
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 11
- 235000019640 taste Nutrition 0.000 claims abstract description 10
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 9
- 235000011124 aluminium ammonium sulphate Nutrition 0.000 claims abstract description 9
- 235000011126 aluminium potassium sulphate Nutrition 0.000 claims abstract description 9
- 239000001110 calcium chloride Substances 0.000 claims abstract description 9
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 9
- 229940050271 potassium alum Drugs 0.000 claims abstract description 9
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims abstract description 9
- 235000011148 calcium chloride Nutrition 0.000 claims abstract description 6
- 235000011147 magnesium chloride Nutrition 0.000 claims abstract description 6
- LCQXXBOSCBRNNT-UHFFFAOYSA-K ammonium aluminium sulfate Chemical compound [NH4+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCQXXBOSCBRNNT-UHFFFAOYSA-K 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 2
- 150000003278 haem Chemical class 0.000 claims description 57
- 244000144972 livestock Species 0.000 claims description 5
- 244000144977 poultry Species 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 abstract description 6
- 241000272496 Galliformes Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 108010054147 Hemoglobins Proteins 0.000 description 14
- 102000001554 Hemoglobins Human genes 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- WZUKKIPWIPZMAS-UHFFFAOYSA-K Ammonium alum Chemical compound [NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O WZUKKIPWIPZMAS-UHFFFAOYSA-K 0.000 description 5
- 239000010802 sludge Substances 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 108010036302 hemoglobin AS Proteins 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- IMWCPTKSESEZCL-SPSNFJOYSA-H (e)-but-2-enedioate;iron(3+) Chemical compound [Fe+3].[Fe+3].[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O.[O-]C(=O)\C=C\C([O-])=O IMWCPTKSESEZCL-SPSNFJOYSA-H 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【発明の詳細な説明】
(イ1発明の目的
本発明は、家畜類や家禽類の血液をもとにして得られる
鉄高含有ヘム鉄に関する。DETAILED DESCRIPTION OF THE INVENTION (1) Object of the Invention The present invention relates to iron-rich heme iron obtained from the blood of livestock and poultry.
「産業上の利用分野」
家畜、家禽の屠殺に際して出る血液に関しては1種々の
加工が施され、食品、医薬品の原料として、又、工業用
素材として有効利用されている。さらに、血液中の血餅
な構成するヘモグロビンは、加工食品であるハムの着色
剤や結着剤としても多く利用され、今後もその方面の利
用は、拡大されど言われている。一方、最近のヘモグロ
ビンの新しい応用分野に、鉄の供給源として貧血各回け
の栄り補助食品、あるいは医薬品への利用が注目される
ようになってきている。``Industrial Application Fields'' The blood produced when livestock and poultry are slaughtered is processed in a variety of ways, and is effectively used as a raw material for foods and medicines, as well as as an industrial material. Furthermore, hemoglobin, which makes up blood clots, is often used as a coloring agent and binding agent for processed ham, and its use in these areas is expected to continue to expand in the future. On the other hand, recently, new fields of application of hemoglobin are attracting attention, such as its use as a source of iron in nutritional supplements for treating anemia or in pharmaceuticals.
従来の鉄欠乏性貧血愚考又は貧血体質者にはその治療や
予防を目的として、硫酸第1鉄、酸化鉄などの無機鉄、
又、クエン酸鉄、フマール酸鉄などの有機鉄(以下、無
機鉄を含めて非ヘム鉄という)を鉄則として含む医薬品
や食品が用いられるのが一般的であったが、これらの非
ヘム鉄は、概して、体内における吸収効率が低(、それ
なりの効果を求めようとする場合、摂取量を多くする必
要があり、消化器官、特に、胃を荒らす場合が多いこと
から敬遠されがちであった。For the treatment and prevention of iron deficiency anemia or those with anemia, inorganic iron such as ferrous sulfate and iron oxide,
In addition, it was common to use pharmaceuticals and foods that contain organic iron (hereinafter referred to as non-heme iron, including inorganic iron) such as iron citrate and iron fumarate, but these non-heme iron In general, they tend to be avoided because they have a low absorption efficiency in the body (if you want to achieve a certain effect, you need to take a large amount of them, and they often irritate the digestive system, especially the stomach). .
他方、ヘモグロビン中に含まれる鉄(以下、ヘム鉄とい
う)は、前述の非ヘム鉄に比較して、生物学的利用率も
高く、胃を始めとして消化気管への弊害もほとんどなく
、新しい鉄供給源として見立されてきている。On the other hand, iron contained in hemoglobin (hereinafter referred to as heme iron) has a higher bioavailability than the non-heme iron mentioned above, has almost no adverse effects on the gastrointestinal tract including the stomach, and is a new type of iron. It is being seen as a supply source.
牛、豚、馬、鶏などの家畜、家禽類の血液中成分の10
〜15%を占めるヘモグロビンは、分子1約60.00
0〜70,000の蛋白質で、その1分子に4分子のプ
ロトヘムが結合している。10 blood components of livestock such as cows, pigs, horses, chickens, and poultry
Hemoglobin, which accounts for ~15%, has approximately 60.00 molecules per molecule.
0 to 70,000 proteins, each molecule of which has 4 molecules of protoheme bound to it.
ヘモグロビン1分子中に含まれる鉄は、018〜0,2
4%程度で2食物として人が摂取した場合、ヘモグロビ
ンは消化吸収され、含まれる鉄は、人のヘモグロビンの
合成に利用される。Iron contained in one molecule of hemoglobin ranges from 018 to 0,2
When humans ingest about 4% of hemoglobin as food, hemoglobin is digested and absorbed, and the iron contained is used to synthesize human hemoglobin.
我々人間は、ヘモグロビンをそのまま食べる習慣は無く
、普通は動物のレバー料理又は肉料理などで摂っている
に過ぎず、前述した様に、貧血の予防5治療を目的とし
た場合は、ヘモグロビンを直接摂った方が、食物量、効
率面からしても、好ましいことは言うまでもない。We humans do not have the habit of eating hemoglobin as it is; we usually only get it from animal liver dishes or meat dishes. Needless to say, it is better to consume it in terms of food quantity and efficiency.
「従来の技術」
動物の血液からヘモグロビンを得るには、血液を摂取し
たのち、溶血させ、遠心分離機によって血餅部分を分取
し、水、有機溶媒等による洗浄によって、繊維質、塩な
どの不純物を取り除いて精製される。``Prior art'' To obtain hemoglobin from animal blood, the blood is ingested, hemolysed, the clot portion is separated using a centrifuge, and fibers, salts, etc. are separated by washing with water, organic solvents, etc. It is purified by removing impurities.
蛋白を主体とするヘモグロビンは、安定化するために、
1111a92燈操作によって得られる粉体(血粉−ヘ
モグロビン)の型で市場に提供されるのが一般的である
。この血粉を可食グレードに仕上げ、一部貧血者向けの
食品に利用するわけであるが、血粉中の鉄含量は、前に
も述べたごとく、高々0.24%程度のものであり、例
えば、成人女性の1日の鉄必要Ill l Om gを
、血粉のみから摂取しようと仮定すると、利用効率を考
慮に入れると、10g以上を食べる必要があり、血液特
有の生臭さも手伝って、とても摂取不可能な量となって
しまう、こうしたことから、ヘモグロビンをある種の蛋
白分解酵素を用いて処理し、1臼含量の少ない、つまり
、鉄含有率の高いヘム鉄を製造し、 l1ii述の用途
に供しようとする動きが見られる。In order to stabilize hemoglobin, which is mainly composed of protein,
It is generally provided on the market in the form of a powder (blood meal-hemoglobin) obtained by 1111a92 light operation. This blood powder is made into an edible grade and used as food for some anemic people, but as mentioned earlier, the iron content in blood powder is at most 0.24%, for example. Assuming that an adult woman's daily iron requirement is to be ingested only from blood meal, taking utilization efficiency into account, it would be necessary to eat more than 10 g, and with the fishy odor characteristic of blood, it would be extremely difficult to ingest iron. Therefore, hemoglobin is treated with a certain type of proteolytic enzyme to produce heme iron with a low iron content, that is, a high iron content, and it is used for the purposes described in 1ii. There are signs that there is a movement to provide this.
そうした鉄高含有ヘム鉄製造の従来法の一例を明記する
と以下の様である。An example of the conventional method for producing heme iron with high iron content is as follows.
(従来法)
不純物を取り除いた新鮮な牛血液100Qを遠心分離し
、血餅約40Kgを得る。これに2,5倍1の水を加λ
て瀉血させた後、水酸化ナトリウムを通1用いてPH8
,5に調整する。攪拌下に蛋白分解酵素(アルカラーゼ
0.6L ノボインダストリー社製)1.2Kgを加
えて、fAAs2℃で3時間加水分解を行う1反応終了
後、系の温度を上昇させて酵素を失活させた後、塩酸を
用いてpH4,0以下に調整する。(Conventional method) 100Q of fresh bovine blood from which impurities have been removed is centrifuged to obtain approximately 40 kg of blood clot. Add 2.5 times 1 part water to this
After exsanguination, the pH was adjusted to 8 using sodium hydroxide.
,5. 1.2 kg of protease (Alcalase 0.6 L manufactured by Novo Industries) was added under stirring and fAAs was hydrolyzed at 2°C for 3 hours. After one reaction, the temperature of the system was raised to inactivate the enzyme. Afterwards, adjust the pH to 4.0 or less using hydrochloric acid.
この際、析出する析出物(鉄含有率の高いヘモグロビン
分解物)を遠心分離機にて、ペースト状に回収し、さら
に、このペーストに水を加えて洗浄することによって、
塩等の夾雑物を取り除いた後、再度、遠心分離機を用い
て、ペースト状にして目的物を回収する0次いで、スプ
レードライヤーを用いて&ff1L、鉄高倉量ヘム鉄2
.OKgを得る。ここで得られたヘム鉄は鉄を1.1%
含有している。At this time, the precipitate (hemoglobin decomposition product with high iron content) is collected in a paste form using a centrifuge, and water is added to this paste for washing.
After removing impurities such as salt, use a centrifuge again to make a paste and recover the target material. Next, use a spray dryer to remove
.. Get OKg. The heme iron obtained here contains 1.1% iron.
Contains.
しかし、鉄高含有ヘム鉄の市場への供給能力、商品価値
を考え合わせた場合、こうした従来の方法では、次のよ
うな問題点があることが否めない。However, when considering the ability to supply high-iron content heme iron to the market and the commercial value, it is undeniable that these conventional methods have the following problems.
その1つは、T!A造工程中、系のpHを酸性側へ移行
させることによって析出してくる目的物(鉄高含有ヘム
鉄)は、非常に微細な結晶であることや共存する分解液
がアミノ酸等を多1に含むため、気泡性に富もことなど
から、遠心分離機やフィルタープレス、その他の回暇機
による回収効率が非常に琶<、回収コストが高くつくこ
とになり、必然的に製品単価にはね返り、市場性も低く
なる。実際、前述の製造法によれば、y、含有の理論値
からしても、3.5Kg程度のヘム鉄が得られても良い
はずであるが、2.0Kg (57%の収!りと回収率
が悪い、又、得られた鉄高含有ヘム鉄は、血液由来物特
有の生臭さを持っており。One of them is T! During the A manufacturing process, the target product (heme iron with high iron content) that is precipitated by shifting the pH of the system to the acidic side is a very fine crystal, and the coexisting decomposition liquid contains many amino acids, etc. Because it contains a lot of air bubbles, the collection efficiency using centrifuges, filter presses, and other recycling machines is very low, and the collection cost is high, which inevitably increases the product price. , marketability will also be lower. In fact, according to the above-mentioned production method, even from the theoretical value of y and content, it should be possible to obtain about 3.5 kg of heme iron, but 2.0 kg (57% yield! The recovery rate is poor, and the obtained heme iron with high iron content has a fishy odor characteristic of blood-derived products.
未加工の血粉に比して、使用量が少なくて済むと言って
も、やはり食品として口にしがたい欠点は、解消されて
いないのである。Even though it can be used in a smaller amount than unprocessed blood powder, it still has the drawbacks that make it difficult to eat as a food.
[発明が解消しようとする課題」
そこで本発明者らは、先に特開昭63−276460に
おいて開示したごとく、鉄を高濃度に含有するヘム鉄の
製造工程中において、天然カチオン高分子であるキトサ
ンを用いて、動物血液由来の特有の生臭みや味を除去す
ることによって、摂取しゃすいヘム鉄を市場に供給する
ことを可能としたのであるが、更に、こうした一連の研
究を発展させ、より品質の向上したヘム鉄製品の開発を
目的として、鋭意努力した結果、本発明を成功するに至
った。[Problems to be Solved by the Invention] Therefore, as previously disclosed in JP-A No. 63-276460, the present inventors discovered that during the production process of heme iron, which contains a high concentration of iron, a natural cationic polymer. By using chitosan to remove the characteristic fishy odor and taste derived from animal blood, we were able to supply the market with easily ingested heme iron. As a result of diligent efforts aimed at developing heme iron products with improved quality, the present invention has been successfully achieved.
[口]発明の構成
本発明は家畜類、家禽類の血液からヘモグロビンを分離
、これを加水分解することによって鉄として0.25%
以上を含む生臭い味を持たない、鉄高含有ヘム鉄及びそ
の製造法にある。[Example] Structure of the invention The present invention separates hemoglobin from the blood of livestock and poultry, and hydrolyzes it to produce 0.25% iron.
To provide heme iron with a high iron content and a method for producing the same, which does not have a fishy taste including the above.
製造法としては、工程中に塩化マグネシウム、塩化カル
シウム、カリウムミョウバン、アンモニムミョウバンを
使用することを特徴とし、又、その使用量が精製された
ヘム鉄に対して、0.0001〜2.0%の範囲内であ
ることも一つの特徴である。詳しくは以下に開示する。The manufacturing method is characterized by the use of magnesium chloride, calcium chloride, potassium alum, and ammonium alum during the process, and the amount used is 0.0001 to 2.0 per purified heme iron. Another feature is that it is within the range of %. Details are disclosed below.
(実施例1)
不純物を取り除いた新鮮な牛血液1000Kgを遠心分
離し、血餅的400Kgを得る。これに2.5倍量の水
を加えて溶血させる。(別に出発原料として牛血液を同
様に溶血させ、ヘモグロビンのみを遠心分M機等で回収
し、噴霧乾燥法で乾燥させ血粉となした後、雑菌処理を
行って可食グレードとして市場されている。−船名・ヘ
モグロビンパウダー150Kgを1500βの水に分散
溶解させたものでも可能である)次いで、水酸化ナトリ
ウムを1lJt用いて、pHを8.5に調製した後、攪
拌下に蛋白分解酵素8〜12Kgを加えて2温度約50
℃で4〜5時間加水分解を行う。(Example 1) 1000 kg of fresh bovine blood from which impurities have been removed is centrifuged to obtain 400 kg of blood clot. Add 2.5 times the amount of water to this to cause hemolysis. (Separately, bovine blood is similarly hemolysed as a starting material, only the hemoglobin is recovered using a centrifugal M machine, etc., dried using a spray drying method to make blood powder, and then treated with germs and marketed as an edible grade. (It is also possible to disperse and dissolve 150 kg of hemoglobin powder in 1500 β water) Next, after adjusting the pH to 8.5 using 1 lJt of sodium hydroxide, add 8.5 g of protease while stirring. ~ Add 12Kg and 2 temperatures approx. 50
Hydrolysis is carried out for 4-5 hours at <0>C.
酵素反応終了後、系の温度を上昇させて、酵素を失活さ
せた後、系の温度を40℃以下に降温させ、別に、塩化
マグネシウム01%含有水溶液lOaを加えて全体が均
一になる様に良く撹拌した後。塩酸を用いてpH4,0
付近に調製する。After the enzymatic reaction is completed, the temperature of the system is raised to inactivate the enzyme, and then the temperature of the system is lowered to below 40°C, and separately, 1Oa of an aqueous solution containing 01% magnesium chloride is added to make the whole homogeneous. After stirring well. pH 4.0 using hydrochloric acid
Prepare nearby.
この操作によって、鉄含有が高いヘム鉄が折とするので
1次いでフィルタープレス機を用いて。By this operation, heme iron with a high iron content is lost, so first, a filter press was used.
不溶物をスラッジとして回収する。スラッジは湿体ff
E Iffとして約200Kgの物であり、このスラッ
ジを再度反応タンクに返して、約200042の水を加
えて撹拌しながら水洗を行う。05〜1時間程程度水洗
後、再びフィルタープレス機を用いて70〜80℃の温
度で乾燥した後、粉砕して、目的とする鉄高含有ヘム鉄
を得る。Collect insoluble matter as sludge. Sludge is a wet substanceff
The sludge weighs approximately 200 kg as E Iff, and this sludge is returned to the reaction tank again, and approximately 200,042 kg of water is added and washed with water while stirring. After washing with water for about 0.5 to 1 hour, it is dried again using a filter press at a temperature of 70 to 80°C, and then pulverized to obtain the desired heme iron with high iron content.
これによって得られる鉄高含有ヘム鉄の鉄含有量は、1
.0〜2.1%程度であった。The iron content of the iron-rich heme iron obtained by this method is 1
.. It was about 0 to 2.1%.
尚、得られたヘム鉄は、従来法によって得られたヘム鉄
に比較して、生臭い臭いや味が極端に少なく、食品とし
ての価値も非常に高いものであった。The obtained heme iron had extremely less fishy odor and taste than heme iron obtained by conventional methods, and had a very high value as a food product.
(実施例2)
実施例1で使用した塩化マグネシウム0.1%含有水溶
液10βの代りに、塩化カルシウム01%含有水fa′
filOQを使用する他は、実施例1と同様の操作を行
う。(Example 2) Instead of the aqueous solution 10β containing 0.1% magnesium chloride used in Example 1, water fa' containing 01% calcium chloride was used.
The same operations as in Example 1 are performed except for using filOQ.
尚、塩化カルシウムを使用した場合においても、生臭い
臭いや味の改良は可能であった。Incidentally, even when calcium chloride was used, it was possible to improve the fishy odor and taste.
(実施例3)
実施例1で使用した塩化マグネシウム0.1%含有水溶
JfLtogの代りに、カリウムミョウバン又はアンモ
ニウムミョウバン0.5%含有水溶液lOQを使用する
他は、実施例1と同様の操作を行う。尚、カリウムミョ
ウバン又は、アンモニウムミョウバンを使用した場合に
おいても、生臭い臭いや味の改良は可能であった。(Example 3) The same operation as in Example 1 was carried out, except that instead of the aqueous solution JfLtog containing 0.1% magnesium chloride used in Example 1, an aqueous solution lOQ containing 0.5% potassium alum or ammonium alum was used. conduct. Incidentally, even when potassium alum or ammonium alum was used, it was possible to improve the fishy odor and taste.
以上、」二記のごと〈実施例1〜3示したように、鉄高
含有ヘム鉄を精製する工程中、塩化マグネシウム、塩化
カルシウム、カリウムミョウバンアンモニウムミョウバ
ンを適当濃度で使用することによって、動物血液由来の
加工品にありがちな生臭い臭い、味を特異的に低減、改
良できることがtJl明し、これによって得られたヘム
鉄の商品価値も非常に高いものであった。As shown in Examples 1 to 3, by using magnesium chloride, calcium chloride, potassium alum, and ammonium alum at appropriate concentrations during the process of refining heme iron with high iron content, animal blood It was revealed that the fishy smell and taste that are common in processed products derived from heme iron can be specifically reduced and improved, and the commercial value of the heme iron obtained thereby was also very high.
(物性及び作用、効果の確認)
前記、実施例1〜3で示す鉄高含有ヘム鉄に係る物性等
の特徴について、試験結果を第1表及び第1〜3図に示
す。(Confirmation of physical properties, actions, and effects) Test results are shown in Table 1 and Figures 1 to 3 regarding the physical properties and other characteristics of the high iron content heme iron shown in Examples 1 to 3 above.
「第1表」 鉄高含有ヘム鉄の物性
「鉄高含有ヘム鉄の物性評価」
本発明の実施45111〜3によって得られた鉄高含有
ヘム鉄のいずれもが、従来法によって得られたヘム鉄に
比べて、第1表に示したごとく、生臭い臭いや味が大幅
に減少していることが[認できる。"Table 1" Physical properties of heme iron with high iron content "Evaluation of physical properties of heme iron with high iron content" All of the heme iron with high iron content obtained by Examples 45111 to 3 of the present invention were different from the heme iron obtained by the conventional method. As shown in Table 1, it can be seen that the fishy odor and taste are significantly reduced compared to iron.
[鉄高含有ヘム鉄の吸収性試験及び評価」本発明中、実
施例1によって得られた鉄高含何(2,08%)ヘム鉄
の人における吸収性を検討すべく以下のような方法で試
験を行った。[Absorption test and evaluation of high-iron content heme iron] In order to examine the absorption in humans of the high-iron content (2.08%) heme iron obtained in Example 1, the following method was used in the present invention. The test was conducted.
健常と思われる男性(25才から48才まで)9人を選
び、ヘム鉄5g(iとして100mg含有)を経口投与
し、時間の経過とともに、血清中の鉄含有量がどのよう
に変化してゆ(かを追跡したものである。Nine apparently healthy men (aged 25 to 48) were given 5g of heme iron (containing 100mg of i) orally, and how the iron content in their serum changed over time. This is the one that tracked Yuka.
尚、裸面時間帯は、以下に示すごとくである。In addition, the bare face time period is as shown below.
ヘム鉄摂取;11(朝食前AM 9:00)ヘム鉄摂
取1時間後 (AM 10:00)ヘム鉄摂取3時間
後 (PM 12+001ヘム鉄枦取7時間後 (P
M 4:001上記のごとく、4回に分けて、各2
.5ccの血液を腕より採血し、血清中の鉄含有量を測
定した。Heme iron intake: 11 (before breakfast 9:00 AM) 1 hour after heme iron intake (AM 10:00) 3 hours after heme iron intake (PM 12+001 7 hours after heme iron intake (P
M 4:001 As above, divided into 4 times, 2 times each
.. Five cc of blood was collected from the arm, and the iron content in the serum was measured.
第1図はヘム鉄摂取による血清鉄の日内変動率を示した
ものであり、第1図よりヘム鉄の摂取は有意に血清中の
鉄含有量の上昇に寄与し、その強度は初期(0時)の血
清鉄属の低い者に対してより効果的であることが判明し
た。Figure 1 shows the diurnal rate of change in serum iron due to heme iron intake. Figure 1 shows that heme iron intake significantly contributes to an increase in serum iron content, and its strength is greater than the initial (0 It was found that it is more effective for people with low serum iron levels.
[ハ)発明の効果
本発明により得られた鉄高含有ヘム鉄は鉄として0,2
5%以上を含み、(実施例によって得られた鉄高含有ヘ
ム鉄は、鉄として0.25%以上〜8.0%を含む)血
液由来物質特有の生臭い臭い、味が殆ど無いことが大き
な特徴である。[C) Effect of the invention The iron-rich heme iron obtained by the present invention has an iron content of 0.2
5% or more (the high iron content heme iron obtained in the example contains 0.25% or more to 8.0% iron). It is a characteristic.
又、酵素による加水分解終了後、目的物を回収するため
に、pt−tを4.0以下に調製しなければならない従
来法によって得られたヘム鉄は、酸による刺激味が感じ
られるが1本発明によって得られるヘム鉄は、刺激味の
無い良好な品質のものであることも判明した。In addition, heme iron obtained by the conventional method, in which the pt-t must be adjusted to 4.0 or less in order to recover the target product after hydrolysis by enzymes is completed, has a pungent taste due to acid. It has also been found that the heme iron obtained by the present invention is of good quality and has no irritating taste.
一方、ヘム鉄製造工程中における操作性に関しても1本
発明によれば塩化マグネシウム、塩化カルシウム、カリ
ウムミョウバン、アンモニウムミョウバン等の蛋白凝集
効果によって、スラッジの凝集を促進させ、遠心分離機
やフィルタープレス等の濾過機による固−液分離を容易
にするなどの利点がある。On the other hand, with regard to operability during the heme iron manufacturing process, according to the present invention, sludge aggregation is promoted by the protein aggregation effect of magnesium chloride, calcium chloride, potassium alum, ammonium alum, etc., and centrifugal separators, filter presses, etc. It has the advantage of facilitating solid-liquid separation using a filter.
本発明の効果は上記したごとくであり2品質の面でも製
造作業性の面でも従来法に比して飛躍的に向上したヘム
鉄が得られ、本発明によって、ヘム鉄の加工食品、医薬
品への応用が更に拡大することが期待出来る。The effects of the present invention are as described above.2 Heme iron can be obtained that is dramatically improved in terms of quality and manufacturing workability compared to conventional methods. It is expected that the application of this technology will further expand.
第1図は、ヘム鉄、経口投与による血清鉄の変動を時間
差において示したものである。
尚、ヘム鉄摂取前の値を0として、変動率(%)を求め
た。
第2図は、実施15+Ilによって得られた鉄高含有ヘ
ム鉄を、KBr錠剤法によって赤外線吸収スペクトルを
求めたものである。
第3図は、本発明による鉄高含有ヘム鉄の紫外部から可
視部にわたる吸収スペクトルを示すものである。尚、第
3図中、Aは実施例1〜3によって得られた鉄高含有ヘ
ム鉄、Bは従来法による鉄高含有ヘム鉄、Cは加水分解
処理以前の未処理血粉である。FIG. 1 shows changes in serum iron due to heme iron and oral administration over time. Incidentally, the fluctuation rate (%) was calculated by setting the value before heme iron intake as 0. FIG. 2 shows the infrared absorption spectrum of the iron-rich heme iron obtained in Example 15+Il using the KBr tablet method. FIG. 3 shows the absorption spectrum of the iron-rich heme iron according to the present invention ranging from the ultraviolet region to the visible region. In addition, in FIG. 3, A is iron-rich heme iron obtained in Examples 1 to 3, B is iron-rich heme iron obtained by the conventional method, and C is untreated blood powder before hydrolysis treatment.
Claims (3)
グネシウム、塩化カルシウム、カリウムミヨウバン、ア
ンモニムミョウバンのいずれかで処理し、血液由来物質
特有の生臭い臭気及び味が、ほとんどないことを特徴と
する鉄高含有ヘム鉄。(1) When quantifying, the iron content is 0.25% or more, treated with magnesium chloride, calcium chloride, potassium alum, or ammonium alum, and the fishy odor and taste characteristic of blood-derived substances are almost eliminated. High iron content heme iron characterized by no iron content.
鉄の製造工程中において、塩化マグネシウム、塩化カル
シウム、カリウムミョウバン、アンモニムミョウバンの
いずれかを使用することを特徴とする鉄高含有ヘム鉄の
製造法。(2) It is characterized in that one of magnesium chloride, calcium chloride, potassium alum, and ammonium alum is used during the production process of high iron content heme iron obtained by processing the blood of livestock and poultry. Production method of high iron content heme iron.
マグネシウム、塩化カルシウム、カリウムミョウバン、
アンモニムミョウバンの量が精製されたヘム鉄に対して
、0.0001〜2.0%の範囲であることを特徴とす
る鉄高含有ヘム鉄の製造法。(3) Magnesium chloride, calcium chloride, potassium alum, used in the manufacturing process of high iron content heme iron,
A method for producing heme iron with high iron content, characterized in that the amount of ammonium alum is in the range of 0.0001 to 2.0% based on purified heme iron.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1144427A JPH0310659A (en) | 1989-06-07 | 1989-06-07 | Iron-rich hemoferrum and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1144427A JPH0310659A (en) | 1989-06-07 | 1989-06-07 | Iron-rich hemoferrum and production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0310659A true JPH0310659A (en) | 1991-01-18 |
JPH0458946B2 JPH0458946B2 (en) | 1992-09-18 |
Family
ID=15361940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1144427A Granted JPH0310659A (en) | 1989-06-07 | 1989-06-07 | Iron-rich hemoferrum and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0310659A (en) |
Cited By (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5980585A (en) * | 1997-12-16 | 1999-11-09 | L'oreal | Compositions for dyeing keratinous fibers comprising imidazopyridine derivatives and process |
US6027538A (en) * | 1997-08-25 | 2000-02-22 | L'oreal S.A. | Compositions for dyeing keratinous fibers comprising indazoleamine derivatives and dyeing process |
WO2004043330A2 (en) | 2002-11-07 | 2004-05-27 | L'oreal | Cosmetic composition comprising at least one specific cyclic carbonate which may be polymerised |
US6846333B2 (en) | 2001-11-08 | 2005-01-25 | L'oreal, S.A. | Keratin fiber dyeing composition comprising a particular aminosilicone |
EP1716841A1 (en) | 2002-12-06 | 2006-11-02 | L'Oréal | Composition for the oxidative dyeing of keratinic fibers |
EP1990043A1 (en) | 2007-05-07 | 2008-11-12 | L'Oreal | Composition for dyeing keratinous fibres comprising at least one specific amine silicone and monoethanolamine |
EP2092933A1 (en) | 2008-02-22 | 2009-08-26 | L'Oréal | Use of particular cationic polymers in a dye composition and associated with a chelating agent as antioxidants or free-radical scavengers |
EP2092961A1 (en) | 2008-02-22 | 2009-08-26 | L'Oréal | Use of particular cationic polymers as anti-oxidant or anti-radical agents |
EP2198840A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Composition for the oxidative dyeing of keratinous fibres comprising a fatty material and a diaminopyrazolone derivative |
EP2198839A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Composition for the oxidative dyeing of keratinous fibres comprising a fatty material and a 4,5-diamino-pyrazole derivative |
EP2198846A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Oxidative hair dye composition comprising a fatty component, a thickener and a dye precursor. |
EP2198853A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Composition for the oxidative dyeing of keratinous fibres comprising a fatty material and N,N bis-(beta-hydroxyethyl)-paraphenylenediamine |
EP2198845A2 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Oxydative dye composition for keratin fibres comprising a para-aminophenol and dipropylene glycol |
EP2246039A1 (en) | 2009-04-30 | 2010-11-03 | L'Oréal | Method for dyeing hair comprising the step of treating the hair with an organic silicon compound |
EP2275082A1 (en) | 2002-12-06 | 2011-01-19 | L'Oréal | Composition for oxidation dyeing keratin fibers comprising a nonionic associative polymer, a specific cellulosic compound and a specific cationic polymer. |
WO2012021577A1 (en) | 2010-08-10 | 2012-02-16 | L'oreal Usa | Silicone based cosmetic compositions and uses thereof |
WO2012032671A1 (en) | 2010-09-08 | 2012-03-15 | L'oreal | Cosmetic composition for keratin fibers |
WO2012032673A1 (en) | 2010-09-08 | 2012-03-15 | L'oreal | Cosmetic composition for keratin fibers |
WO2012069599A2 (en) | 2010-11-25 | 2012-05-31 | L'oreal | Process for stripping keratin fibres using a composition comprising a sulfinic acid derivative and an acidic aqueous composition |
WO2012175687A2 (en) | 2011-06-24 | 2012-12-27 | L'oreal | Emulsion dyeing composition containing an amine or a phospholipid, at least one nonionic surfactant and at least one phosphate ester, and method of using same |
WO2012175685A2 (en) | 2011-06-24 | 2012-12-27 | L'oreal | Emulsion dyeing composition containing an amine or a phospholipid, at least one nonionic surfactant and at least one silicone, and method of using same |
WO2012175688A2 (en) | 2011-06-24 | 2012-12-27 | L'oreal | Emulsion dyeing composition containing an amine or a phospholipid, at least one nonionic surfactant and at least one carboxylic acid, and method of using same |
WO2013069167A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013069166A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013069168A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013069165A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013098335A2 (en) | 2011-12-30 | 2013-07-04 | L'oreal | Process for altering the appearance of hair using a composition containing dyes and non-hydroxide bases |
WO2013121592A1 (en) | 2012-02-14 | 2013-08-22 | L'oreal | Cosmetic composition and process for coloring and bleaching of human keratin fibers |
WO2013125054A1 (en) | 2012-02-24 | 2013-08-29 | L'oreal | Process for treating keratin fibers |
WO2013150661A1 (en) | 2012-04-04 | 2013-10-10 | L'oreal | Cosmetic composition for keratin fibers |
WO2013153677A1 (en) | 2012-04-10 | 2013-10-17 | L'oreal | Cosmetic composition for keratin fibers |
WO2014053504A2 (en) | 2012-10-02 | 2014-04-10 | L'oreal | Agent for altering the color of keratin fibers containing a fatty substance and a rheology modifying polymer in an emulsion system |
WO2016084971A1 (en) | 2014-11-26 | 2016-06-02 | L'oreal | Silicone oil-rich composition |
WO2016084972A1 (en) | 2014-11-26 | 2016-06-02 | L'oreal | Oil-rich composition |
WO2020142521A1 (en) | 2018-12-31 | 2020-07-09 | L'oreal | Hair coloring compositions and methods of use |
WO2022075204A1 (en) | 2020-10-07 | 2022-04-14 | L'oreal | Composition for keratin fibers |
WO2022075203A1 (en) | 2020-10-07 | 2022-04-14 | L'oreal | Composition for keratin fibers |
FR3115987A1 (en) | 2020-11-06 | 2022-05-13 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
FR3116199A1 (en) | 2020-11-17 | 2022-05-20 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
FR3117017A1 (en) | 2020-12-07 | 2022-06-10 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
WO2023106218A1 (en) | 2021-12-08 | 2023-06-15 | L'oreal | Composition for keratin fibers |
FR3131696A1 (en) | 2022-01-13 | 2023-07-14 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
WO2023228870A1 (en) | 2022-05-25 | 2023-11-30 | L'oreal | Composition for coloring keratin fibers |
FR3141064A1 (en) | 2022-10-19 | 2024-04-26 | L'oreal | Hair coloring compositions |
-
1989
- 1989-06-07 JP JP1144427A patent/JPH0310659A/en active Granted
Cited By (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6027538A (en) * | 1997-08-25 | 2000-02-22 | L'oreal S.A. | Compositions for dyeing keratinous fibers comprising indazoleamine derivatives and dyeing process |
US5980585A (en) * | 1997-12-16 | 1999-11-09 | L'oreal | Compositions for dyeing keratinous fibers comprising imidazopyridine derivatives and process |
US6846333B2 (en) | 2001-11-08 | 2005-01-25 | L'oreal, S.A. | Keratin fiber dyeing composition comprising a particular aminosilicone |
WO2004043330A2 (en) | 2002-11-07 | 2004-05-27 | L'oreal | Cosmetic composition comprising at least one specific cyclic carbonate which may be polymerised |
EP1716841A1 (en) | 2002-12-06 | 2006-11-02 | L'Oréal | Composition for the oxidative dyeing of keratinic fibers |
EP2275082A1 (en) | 2002-12-06 | 2011-01-19 | L'Oréal | Composition for oxidation dyeing keratin fibers comprising a nonionic associative polymer, a specific cellulosic compound and a specific cationic polymer. |
EP1990043A1 (en) | 2007-05-07 | 2008-11-12 | L'Oreal | Composition for dyeing keratinous fibres comprising at least one specific amine silicone and monoethanolamine |
EP2092933A1 (en) | 2008-02-22 | 2009-08-26 | L'Oréal | Use of particular cationic polymers in a dye composition and associated with a chelating agent as antioxidants or free-radical scavengers |
EP2092961A1 (en) | 2008-02-22 | 2009-08-26 | L'Oréal | Use of particular cationic polymers as anti-oxidant or anti-radical agents |
EP2198846A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Oxidative hair dye composition comprising a fatty component, a thickener and a dye precursor. |
EP2198839A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Composition for the oxidative dyeing of keratinous fibres comprising a fatty material and a 4,5-diamino-pyrazole derivative |
EP2198853A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Composition for the oxidative dyeing of keratinous fibres comprising a fatty material and N,N bis-(beta-hydroxyethyl)-paraphenylenediamine |
EP2198845A2 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Oxydative dye composition for keratin fibres comprising a para-aminophenol and dipropylene glycol |
EP2198840A1 (en) | 2008-12-19 | 2010-06-23 | L'oreal | Composition for the oxidative dyeing of keratinous fibres comprising a fatty material and a diaminopyrazolone derivative |
EP2246039A1 (en) | 2009-04-30 | 2010-11-03 | L'Oréal | Method for dyeing hair comprising the step of treating the hair with an organic silicon compound |
WO2012021577A1 (en) | 2010-08-10 | 2012-02-16 | L'oreal Usa | Silicone based cosmetic compositions and uses thereof |
WO2012032671A1 (en) | 2010-09-08 | 2012-03-15 | L'oreal | Cosmetic composition for keratin fibers |
WO2012032673A1 (en) | 2010-09-08 | 2012-03-15 | L'oreal | Cosmetic composition for keratin fibers |
WO2012069599A2 (en) | 2010-11-25 | 2012-05-31 | L'oreal | Process for stripping keratin fibres using a composition comprising a sulfinic acid derivative and an acidic aqueous composition |
WO2012175687A2 (en) | 2011-06-24 | 2012-12-27 | L'oreal | Emulsion dyeing composition containing an amine or a phospholipid, at least one nonionic surfactant and at least one phosphate ester, and method of using same |
WO2012175685A2 (en) | 2011-06-24 | 2012-12-27 | L'oreal | Emulsion dyeing composition containing an amine or a phospholipid, at least one nonionic surfactant and at least one silicone, and method of using same |
WO2012175688A2 (en) | 2011-06-24 | 2012-12-27 | L'oreal | Emulsion dyeing composition containing an amine or a phospholipid, at least one nonionic surfactant and at least one carboxylic acid, and method of using same |
WO2013069167A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013069166A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013069168A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013069165A1 (en) | 2011-11-09 | 2013-05-16 | L'oreal | Cosmetic composition for keratin fibers |
WO2013098335A2 (en) | 2011-12-30 | 2013-07-04 | L'oreal | Process for altering the appearance of hair using a composition containing dyes and non-hydroxide bases |
WO2013121592A1 (en) | 2012-02-14 | 2013-08-22 | L'oreal | Cosmetic composition and process for coloring and bleaching of human keratin fibers |
WO2013125054A1 (en) | 2012-02-24 | 2013-08-29 | L'oreal | Process for treating keratin fibers |
WO2013150661A1 (en) | 2012-04-04 | 2013-10-10 | L'oreal | Cosmetic composition for keratin fibers |
WO2013153677A1 (en) | 2012-04-10 | 2013-10-17 | L'oreal | Cosmetic composition for keratin fibers |
WO2014053504A2 (en) | 2012-10-02 | 2014-04-10 | L'oreal | Agent for altering the color of keratin fibers containing a fatty substance and a rheology modifying polymer in an emulsion system |
WO2016084971A1 (en) | 2014-11-26 | 2016-06-02 | L'oreal | Silicone oil-rich composition |
WO2016084972A1 (en) | 2014-11-26 | 2016-06-02 | L'oreal | Oil-rich composition |
WO2020142521A1 (en) | 2018-12-31 | 2020-07-09 | L'oreal | Hair coloring compositions and methods of use |
WO2022075204A1 (en) | 2020-10-07 | 2022-04-14 | L'oreal | Composition for keratin fibers |
WO2022075203A1 (en) | 2020-10-07 | 2022-04-14 | L'oreal | Composition for keratin fibers |
FR3115987A1 (en) | 2020-11-06 | 2022-05-13 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
FR3116199A1 (en) | 2020-11-17 | 2022-05-20 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
FR3117017A1 (en) | 2020-12-07 | 2022-06-10 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
WO2023106218A1 (en) | 2021-12-08 | 2023-06-15 | L'oreal | Composition for keratin fibers |
FR3131696A1 (en) | 2022-01-13 | 2023-07-14 | L'oreal | COMPOSITION FOR KERATIN FIBERS |
WO2023228870A1 (en) | 2022-05-25 | 2023-11-30 | L'oreal | Composition for coloring keratin fibers |
FR3141064A1 (en) | 2022-10-19 | 2024-04-26 | L'oreal | Hair coloring compositions |
Also Published As
Publication number | Publication date |
---|---|
JPH0458946B2 (en) | 1992-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0310659A (en) | Iron-rich hemoferrum and production thereof | |
US10455849B2 (en) | Method for the preparation of a protein peptide, a protein peptide and use thereof | |
US4199496A (en) | Process for the recovery of chemicals from the shells of crustacea | |
SU1308183A3 (en) | Method of producing extracts,possessing antiulcerous,insulin-like,antilipidic activity promoting nutrition assimilation,from animal carcasses | |
JPH06505982A (en) | Method for producing collagen, collagen produced by this method, and uses of collagen | |
UA77942C2 (en) | Method for aqueous extraction and fractionation of oilseed material | |
JP4955944B2 (en) | Chondroitin calcium sulfate and method for producing the same | |
CN108077940A (en) | A kind of abalone peptide removes fishy smell technique | |
EA006435B1 (en) | Method for producing a nutrition additive, an additive and its use | |
CN101397581A (en) | Method for extracting fishskin collagen polypeptide from fish wastes | |
WO2006101301A1 (en) | Calcium binding amino acid | |
JPH03168064A (en) | Making of powdered flavoring foodstuff using blood of domestic animal | |
JPH03139291A (en) | Method for treating shell of crustacea using enzyme | |
JP2001275599A (en) | Method for producing soybean-processed product having low purine content | |
JPH0242467B2 (en) | ||
CN110734902B (en) | Complex enzyme preparation and application thereof in field of shrimp enzymolysis processing | |
RU2207033C2 (en) | Method for wasteless complex reprocessing of chitin-containing raw material | |
US2468730A (en) | Method of purifying casein | |
JP2945433B2 (en) | Extraction method of squid soft shell | |
KR100399722B1 (en) | Preparation of fish bone powder and calcium absorption accelerating peptide using the enzyme from fish processing waste | |
US2857278A (en) | Production of edible protein products from fish solubles | |
JPS6163247A (en) | Production of globin protein | |
RU2711175C1 (en) | Method of preparing blood corpuscles to be used for food purposes | |
JPH03160951A (en) | Hemoferrum-containing biscuit | |
CN114920825B (en) | Rapid preparation method of fish collagen small peptide chelated calcium |